Interestingly, however, the associations were marginally, but consistently, significant in separate sub-analyses (separately testing the cases with prior history of BCC, FH, or early onset) providing an important cross-validation of our findings and a support for a general role of this SNP in melanoma recurrence, through a mechanism yet to be elucidated. The gene discussed is FH; the disease is skin basal cell carcinoma.